ORF-8063: an early evaluation of a new antianxiety agent.
D000328:Adult; D000437:Alcoholism / Q000150:complications; D001007:Anxiety / Q000188:drug therapy* / Q000209:etiology; D001259:Ataxia / Q000139:chemically induced; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D003989:Dibenzoxazepines / Q000008:administration & dosage; D005461:Fluorine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007659:Ketones / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012893:Sleep Wake Disorders / Q000139:chemically induced; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014717:Vertigo / Q000139:chemically induced
D001552:Benzazepines; D003989:Dibenzoxazepines; D007659:Ketones; D014149:Tranquilizing Agents; D005461:Fluorine